{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:33Z","timestamp":1794047433900,"version":"4.8.0"},"reference-count":12,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.281973","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T04:07:06Z","timestamp":1678939626000},"page":"2855-2858","source":"Crossref","is-referenced-by-count":11,"title":["The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status"],"prefix":"10.3324","volume":"108","author":[{"given":"Man-Chiu","family":"Poon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"D\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibin","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer B","family":"Zotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"53036","doi-asserted-by":"crossref","unstructured":"Poon MC, d'Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: focus on Glanzmann's thrombasthenia and Bernard-Soulier's syndrome. Semin Thromb Hemost. 2018; 44(6):604-614.","DOI":"10.1055\/s-0038-1648233"},{"key":"53037","unstructured":"Novo Nordisk. NovoSeven\u00ae, Summary of product characteristics. 2023. Publisher Full Text|"},{"key":"53038","doi-asserted-by":"crossref","unstructured":"Di Minno G, Zotz RB, d'Oiron R. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia. Haematologica. 2015; 100(8):1031-1037.","DOI":"10.3324\/haematol.2014.121475"},{"key":"53039","doi-asserted-by":"crossref","unstructured":"Poon MC, d'Oiron R, Zotz RB. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention. Haematologica. 2015; 100(8):1038-1044.","DOI":"10.3324\/haematol.2014.121384"},{"key":"53040","unstructured":"EMA. Assessment report NovoSeven. 2023. Publisher Full Text|"},{"key":"53041","doi-asserted-by":"crossref","unstructured":"Murphy MF, Metcalfe P, Ord J, Lister TA, Waters AH. Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions. Br J Haematol. 1987; 67(3):255-260.","DOI":"10.1111\/j.1365-2141.1987.tb02344.x"},{"key":"53042","doi-asserted-by":"crossref","unstructured":"Weinstock C, Schnaidt M. Human leucocyte antigen sensitisation and its impact on transfusion practice. Transfus Med Hemother. 2019; 46(5):356-369.","DOI":"10.1159\/000502158"},{"key":"53043","doi-asserted-by":"crossref","unstructured":"Huguenin Y, Levoir L, Bouton M, Fiore M. High rates of anti-alphaIIbbeta3 antibodies produced by a Glanzmann thrombasthenia patient after first and unique red blood cells administration. Acta Haematol. 2023; 146(1):44-46.","DOI":"10.1159\/000526224"},{"key":"53044","doi-asserted-by":"crossref","unstructured":"Fiore M, d'Oiron R, Pillois X, Alessi MC. Anti-alpha(IIb) beta(3) immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations. Br J Haematol. 2018; 181(2):173-182.","DOI":"10.1111\/bjh.15087"},{"key":"53045","doi-asserted-by":"crossref","unstructured":"Fiore M, Firah N, Pillois X, Nurden P, Heilig R, Nurden AT. Natural history of platelet antibody formation against alphaIIbbeta3 in a French cohort of Glanzmann thrombasthenia patients. Haemophilia. 2012; 18(3):e201-209.","DOI":"10.1111\/j.1365-2516.2011.02744.x"},{"key":"53046","doi-asserted-by":"crossref","unstructured":"Nurden A, Combrie R, Nurden P. Detection of transfused platelets in a patient with Glanzmann thrombasthenia. Thromb Haemost. 2002; 87(3):543-544.","DOI":"10.1055\/s-0037-1613041"},{"key":"53047","doi-asserted-by":"crossref","unstructured":"Santoro C, Rago A, Biondo F. Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients. Haemophilia. 2010; 16(5):805-812.","DOI":"10.1111\/j.1365-2516.2010.02230.x"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281973\/75446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281973\/76136","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11016\/75446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:44Z","timestamp":1794045824000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":12,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281973","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}